Skip to main content
Download PDF

Correction to: PHARC syndrome: an overview

Orphanet Journal of Rare Diseases volume 20, Article number: 10 (2025) Cite this article

The Original Article was published on 05 November 2024

Following publication of the original article [1], we have been notified that Figs. 2 and 3 were switched.

They are now as follows:

Fig. 2
figure 1

Synthesis and degradation of lyso-PS in the mouse brain. PS = phosphatidylserine; ROS = reactive-oxygen species; ox-PS = oxidized phosphatidylserine; FFA = free fatty acid; GPS = glycerophosphoserine

Full size image
Fig. 3
figure 2

Double knockout of ABHD12 and LPCAT3 causes a strong increase in lyso-PS, but not in C20:4 PS and C20:4 lyso-PS. Metabolic pathway diagram illustrating the coordinated regulation of lyso-PS and C20:4 PS levels in the mammalian brain by ABHD12 and LPCAT3. Red arrows indicate the change in lipid content in ABHD12−/−mice, blue arrows indicate the change in lipid content in N-LPCAT3−/− mice and green arrows indicate the change in lipid content in double knockout mice. FFA = free fatty acid, GPS = glycerophosphoserine

Full size image

They should be:

Fig. 2
figure 3

Synthesis and degradation of lyso-PS in the mouse brain. PS = phosphatidylserine; ROS = reactive-oxygen species; ox-PS = oxidized phosphatidylserine; FFA = free fatty acid; GPS = glycerophosphoserine

Full size image
Fig. 3
figure 4

Double knockout of ABHD12 and LPCAT3 causes a strong increase in lyso-PS, but not in C20:4 PS and C20:4 lyso-PS. Metabolic pathway diagram illustrating the coordinated regulation of lyso-PS and C20:4 PS levels in the mammalian brain by ABHD12 and LPCAT3. Red arrows indicate the change in lipid content in ABHD12−/−mice, blue arrows indicate the change in lipid content in N-LPCAT3−/− mice and green arrows indicate the change in lipid content in double knockout mice. FFA = free fatty acid, GPS = glycerophosphoserine

Full size image

The original article was updated.

References

  1. Harutyunyan et al. (2024) PHARC syndrome: an overview (2024). 19:416 DOI: 10.1186/s13023-024-03418-0

Download references

Author information

Authors and Affiliations

  1. Laboratory for Behavioral and Developmental Genetics, Department of Human Genetics, KU Leuven, Louvain, Belgium

    Lusine Harutyunyan, Patrick Callaerts & Sascha Vermeer

  2. Centre of Human Genetics, University Hospitals Leuven, Herestraat 49, Louvain, 3000, Belgium

    Lusine Harutyunyan

  3. Disability Studies, Family Medicine and Population Health, University Antwerp, Antwerp, Belgium

    Lusine Harutyunyan

Authors
  1. Lusine Harutyunyan
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Patrick Callaerts
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Sascha Vermeer
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Sascha Vermeer.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13023-024-03418-0.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harutyunyan, L., Callaerts, P. & Vermeer, S. Correction to: PHARC syndrome: an overview. Orphanet J Rare Dis 20, 10 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13023-024-03491-5

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13023-024-03491-5

Orphanet Journal of Rare Diseases

ISSN: 1750-1172